Development and Validation of the Visual Medical Scale to Evaluate Nail Psoriasis Severity (ViSENPsO®) - Takeaways - MDSpire

Development and Validation of the Visual Medical Scale to Evaluate Nail Psoriasis Severity (ViSENPsO®)

  • By

  • Adilson DaCosta

  • Cláudio de Lélis Filgueiras de Souza

  • Renan Minotto

  • Selam Shah

  • Olga Moshkovich

  • James P. Stansbury

  • Siu-Long Yao

  • April 30, 2026

  • 0 min

Share

  • 1

    Nail psoriasis affects 80%-90% of psoriasis patients, significantly impairing their quality of life and necessitating improved assessment tools.

  • 2

    The ViSENPsO scale was developed as a standardized, user-friendly tool to enhance consistency and reliability in nail psoriasis severity assessment.

  • 3

    Existing tools like the Nail Psoriasis Severity Index are time-consuming and lack precision, leading to inconsistent interrater reliability.

  • 4

    The study involved qualitative interviews with dermatologists and patients to refine the ViSENPsO's content validity and usability.

  • 5

    Further psychometric validation of the ViSENPsO in larger, diverse populations is needed to confirm its applicability in clinical trials.

Original Source(s)

Related Content